Introduction
Idiopathic pulmonary fibrosis (IPF) is the commonest of the idiopathic interstitial pneumonias and carries a poor prognosis with a median survival of 2.5-3 years after diagnosis (1) . The pathogenesis of this devastating disease is not known. The inciting factor for the development of IPF is believed to be alveolar epithelial injury (2) . The epithelial injury may by immunological (either antibody-or cell-mediated), chemical (e.g., reflux of gastric contents), microbial, or particulate (organic or inorganic). As IPF is a heterogeneous disease manifesting as areas of peripheral and basal reticulation with honeycombing interspersed with normal lung (3), it is plausible that the alveolar epithelial injury is secondary to recurrent episodes of reflux of gastric contents and microaspiration. The aim of this study was a comprehensive evaluation of gastroesophageal reflux symptoms, extraesophageal reflux, and H. pylori prevalence in idiopathic pulmonary fibrosis.
There is evidence of high prevalence of up to 90% of classic gastroesophageal reflux disease (GERD) in IPF in a number of studies (4, 5) . Moreover, patients with scleroderma-associated lung fibrosis have significantly increased reflux episodes as compared with scleroderma patients without pulmonary fibrosis (6) . Gastroesophageal reflux is common in general population. However, the annual incidence of IPF is relatively low being 10 per 100 000. In order to study the possible susceptibility factors, we hypothesized that patients with gastroesophageal reflux and H. pylori infection may be at a significantly greater risk of developing pulmonary fibrosis. The likely pathways of H. pylori-induced pulmonary interstitial injury could be direct injury to alveolar epithelial lining in a similar way to injury to gastric mucosal barrier or immune-mediated injury after the aspiration of stomach contents. Aspiration would be more likely since the H. pylori-associated achlorhydria would decrease stimulation of cough reflex.
Exhaled breath condensate (EBC) measurement of pepsin is a reliable noninvasive technique for the detection of extraesophageal reflux in upper airways at the time of reflux episodes (Strugala et al., personal communication). Indeed, a relationship between pulmonary aspiration and increased pepsin concentration in bronchoalveolar lavage has been demonstrated in animal and human studies (7) (8) (9) (10) (11) (12) (13) (14) (15) and is associated with pulmonary inflammation (16) . Hence, it is plausible to suspect that alveolar epithelial injury and fibrosis is a manifestation of toxic effects of gastric enzymes, such as pepsin, and bile salts.
Material and Methods
Patients. The study population comprised patients with IPF diagnosed according to the ATS/ ERS criteria (3) attending the Interstitial Lung Disease Clinic at the University Hospital. The control group included patients with interstitial lung disease of known cause, patients without interstitial lung disease, and normal healthy subjects. The aim was to compare IPF population with potentially matched controls. As patients with rheumatoid-associated interstitial lung disease and chronic obstructive pulmonary disease are frequently encountered in clinical practice, these groups comprised the predominant controls. However, there were patients with other conditions such as sarcoidosis and respiratory infections included in the control population.
Ethical approval was obtained by the Hull and East Riding Research and Ethics Committee (LREC No. 08/H1304/54), and written consent was obtained from all participants.
Study Design. It was a prospective cross-sectional study of subjective evaluation of GERD symptoms and objective evaluation of Helicobacter pylori prevalence and extraesophageal reflux by measurement of pepsin concentration in EBC.
Hull Airway Reflux Questionnaire Study. It has been previously shown that a symptom complex associated with airway reflux can be identified (17) . Based on these symptoms, a validated questionnaire has been developed, which is a sensitive and reproducible tool to assess this symptom complex (18) . As part of investigation of gastroesophageal reflux in IPF, a cohort of 90 age-matched participants were asked to complete the Hull Airway Reflux Questionnaire (HARQ) to assess subjectively the symptoms of gastroesophageal reflux.
Helicobacter Pylori Study. According to the standard protocol, 6 mL of peripheral blood was obtained from 57 patients. The serum was stored at -80°C immediately after centrifugation (1500 RCF at 20°C for 10 minutes). The presence of H. pylori antibody (IgG) was detected by a rapid immunoassay (qualitative ELISA) in serum.
Exhaled Breath Condensate Study. A total of 23 EBC samples were obtained by patients breathing into an automated collection device made of polypropylene tubing connected to a Dreschel flask immersed in crushed ice. The collection of exhaled breath was performed according to the guidelines recommended by the ERS/ATS task force (19) . The patients were asked to breath into the device (normal tidal breathing) for 10 minutes. Approximately 1 mL of EBC was obtained, and 30 μL was tested for the presence of pepsin after centrifugation. The samples were analyzed by a rapid lateral flow (LF) test (Peptest, RD Biomed, UK) using two unique monoclonal antibodies specific to human pepsin. The EBC was evaluated once for each patient. Statistical Analysis. The statistical analysis was performed using SPSS (version 13, Chicago IL). Normally distributed data were analyzed with the unpaired t test, and skewed data were analyzed by the Mann-Whitney U test. Categorical data were analyzed by the Pearson chi-square test. An α value of 5% was considered statistically significant.
Results
The main demographics of study participants in HARQ, H. pylori, and EBC studies are shown in Tables 1, 2, and 3, respectively.
Hull Airway Reflux Questionnaire. The airway reflux questionnaire was completed by 90 participants (40 patients with IPF and 50 controls) for symptom evaluation. The questionnaire is a symptom-based assessment of gastroesophageal and extraesophageal reflux with 14 items, which are scored from 0 to 5. The upper limit of normal for the total score is 13 with a mean of 4. There was a significant difference in the symptom scores on the questionnaire between IPF and control groups (19.6 [SD, 12.4 ] and 3 [SD, 2.9], respectively; unpaired t test, P<0.01) (Fig.) . In fact, 68% of patients with IPF had a score above the upper limit of normal.
Helicobacter Pylori Study. As shown in Table 4 , there was no significant difference in the proportion of patients with IPF and controls in terms of positivity for H. pylori antibody (Pearson chi-square, P=0.419).
Exhaled Breath Condensate Study. The analysis of EBC pepsin was performed for 23 subjects. The study population included 17 patients with IPF and 6 controls. Although pepsin was detectable in EBC from two patients with IPF and none of the controls, there was no significant difference in exhaled breath pepsin between the IPF and control groups (2 of the 17 patients with IPF and none of the 6 controls; Pearson chi-square test, P=0.379).
Discussion
The present study of investigation of gastroesophageal and extraesophageal reflux in idiopathic Data are presented as mean (SD) unless otherwise indicated. IPF, idiopathic pulmonary fibrosis; PPI, proton pump inhibitors; FVC, forced vital capacity; TL CO , total gas transfer for carbon monoxide. (21) evaluated the prevalence of GERD by esophageal manometry and pH studies. They divided the study population into two groups based on the presence of gastroesophageal reflux. In GERD-positive group, 77% had heartburn or regurgitation as compared with 33% in the GERD-negative group supporting the suggestion that esophageal symptoms alone are inadequate markers of gastroesophageal reflux. These studies suggest that gastroesophageal reflux is very common on objective measurement to assess GERD in patients with IPF. However, classic GERD symptoms are not as prevalent as gastroesophageal reflux on objective studies. Our HARQ data show a marked difference in reflux scores between patients with IPF and control subjects. This questionnaire is designed to detect nonacid airway reflux (laryngopharyngeal reflux) that can be brief and occur at repeated intervals. This symptom assessment provides a comprehensive evaluation of both acid and nonacid reflux episodes.
The EBC pepsin measurement was taken in the outpatient clinic (single measurement for each patient), whereas the episodes of reflux over a period of 24 hours indicated by the HARQ may have been occurring infrequently and the EBC possibly missed them.
The prevalence of H. pylori infection varies with geographical location and the laboratory method to identify the infection. In an Australian study (22) , a prevalence of 15% was reported, while a study of Italian villagers showed the prevalence to be as high as 58% (23) . In our study, there were signifi- (24), and combination of H. pylori stool antigen and IgG may offer the best noninvasive method for the detection of H. pylori infection.
This study of investigation of gastroesophageal and extraesophageal reflux in patients with IPF demonstrates that they have a very high incidence of airway reflux symptoms. However, H. pylori infection or single EBC pepsin analysis is not helpful in the diagnosis of gastroesophageal reflux. As the measurement of EBC pepsin is dependent on the timing of reflux symptoms, repeated sampling with a portable device immediately after the symptoms of reflux may increase the diagnostic yield. A larger prospective study to evaluate the contribution of reflux by both detailed subjective and objective measurements including airway pH analysis might be able to address the association in greater detail.
Conclusions
In view of significantly increased airway reflux symptoms, the role of gastroesophageal and extraesophageal reflux in the pathogenesis of idiopathic pulmonary fibrosis should be further explored. Investigation of nonacid reflux may provide us with further insight into the mechanism of alveolar injury by gastrointestinal secretions. Santrauka. Tyrimo tikslas. Idiopatinė plaučių fibrozė (IPF) -tai dažniausiai pasitaikanti idiopatinė intersticinė plaučių pneumonija. Įrodyta, kad sergantieji IPF dažnai serga ir gastroezofaginio refliukso liga. Šio prospektyviojo tyrimo tikslas -įvertinti pacientų, sergančių idiopatine plaučių fibroze, refliuksą analizuojant klausimyno apie refliukso kosulį rezultatus, pepsino kiekį iškvėpto oro kondensate siekiant nustatyti ekstrastemplinį refliuksą ir Helicobacter pylori serologinį tyrimą, įvertinti šios skrandžio bakterijos paplitimą esant idiopatinei plaučių fibrozei.
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Medžiaga ir metodai. Halo klausimynas apie ryklės-gerklų refliuksą pateiktas 40 pacientų, sergančių idiopatine plaučių fibroze, ir 50 kontrolinės grupės pacientų siekiant įvertinti refliukso simptomus. Iškvėpto oro kondensatas surinktas iš 23 pacientų (17 iš jų sirgo IPF, 6 -kontrolinės grupės pacientai), kad šoninės tėkmės metodu būtų įvertintas pepsino kiekis. Taikant ELISA metodą, H. pylori antikūnių tyrimas atliktas 57 pacientams.
Rezultatai. Lyginant su kontroline grupe, sergantiesiems IPF nustatyti gana aukšti Halo klausimyno rezultatai, kai maksimalus taškų skaičius 70 (sergantieji IPF 19,6±12,4; kontrolinės grupės pacientai -3±2,9; p<0,001). Tačiau nenustatyta didelių teigiamo pepsino kiekio skirtumų tarp sergančiųjų IPF ir kontrolinės grupės pacientų (sergantieji IPF 2/17; kontrolinės grupės pacientai 0/6; p=0,38). H. pylori serologinio tyrimo skirtumai taip pat nežymūs (sergantieji IPF 17/34; kontrolinės grupės pacientai 14/23; p=0,42).
